# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Wells Fargo analyst Stan Berenshteyn maintains American Well (NYSE:AMWL) with a Overweight and lowers the price target from ...
American Well (NYSE:AMWL) lowers FY2025 sales outlook from $250.000 million-$260.000 million to $245.000 million-$250.000 milli...
American Well (NYSE:AMWL) sees Q3 sales of $53.000 million-$56.000 million vs $63.281 million analyst estimate.
American Well (NYSE:AMWL) reported quarterly losses of $(1.24) per share which beat the analyst consensus estimate of $(1.73) b...
- Amwell® (NYSE:AMWL), a leading technology-enabled care platform provider, announced that as part of a Leidos-led partnership,...
Piper Sandler analyst Jessica Tassan reiterates American Well (NYSE:AMWL) with a Neutral and lowers the price target from $1...
UBS analyst Kevin Caliendo maintains American Well (NYSE:AMWL) with a Neutral and lowers the price target from $12 to $9.